MArie Plante

Prof. Dr. MArie Plante

orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2011 in Gynecologic Oncology
Verified
Journal Article
Closed access
MPMArie Plante
MArie Plante
JGJean Gregoire
Jean Gregoire
MRMarie-Claude Renaud
Marie-Claude Renaud
MRMichel Roy
Michel Roy

1 September 2004 in Gynecologic Oncology
Verified
Journal Article
Closed access
MPMArie Plante
MArie Plante
MRMarie-Claude Renaud
Marie-Claude Renaud
HFHarel François
Harel François
MRMichel Roy
Michel Roy

1 December 2003 in Gynecologic Oncology
Verified
Journal Article
Closed access
MPMArie Plante
MArie Plante
MRMarie-Claude Renaud
Marie-Claude Renaud
BTBernard Têtu
Bernard Têtu
FHFrançois Harel
François Harel
MRMichel Roy
Michel Roy

1 July 2005 in Gynecologic Oncology
Verified
Journal Article
Closed access
MPMArie Plante
MArie Plante
MRMarie-Claude Renaud
Marie-Claude Renaud
IHIffath A. Hoskins
Iffath A. Hoskins
MRMichel Roy
Michel Roy

1 October 2004 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
JLJohanie Lépine
Johanie Lépine
OBOlivier Bernard
Olivier Bernard
MPMArie Plante
MArie Plante
BTBernard Têtu
Bernard Têtu
GPGeorges Pelletier
Georges Pelletier
Chantal GuillemetteChantal Guillemette
Chantal Guillemette
Uridine diphospho-glucuronosyltransferases (UGTs) inactivate and facilitate the excretion of estrogens to glucuronides (-G), the most abundant circulating estrogen conjugates. The identity of the conjugated estrogens formed by all known overexpressed UGTs (n = 16) was analyzed by comparison with retention time and mass fragmentation of authentic standards by HPLC tandem mass spectrometry methods. Six UGTs, namely 1A1, 1A3, 1A8, 1A9, 1A10, and 2B7, were found to glucuronidate estradiol (E(2)) and estrone (E(1)), their hydroxyls (OH), and their methoxy derivatives (MeO). Addition of glucuronic acid was catalyzed by specific UGTs at positions 2, 3, and 4 of the estrogens, whereas only E(2) was conjugated at position 17 by UGT2B7. Kinetic parameters indicate that the conjugation of E(2) at position 3 was predominantly catalyzed by 1A1, 1A3, and 1A8 and by 1A8 for E(1). Conjugation of 2-OHE(1)/E(2) and 2- and 4-MeOE(1)/E(2) was selective at position 3, mostly catalyzed by 1A1 and 1A8. Of all UGTs, UGT2B7 demonstrated the highest catalytic activities for estrogens and at least 10- to 50-fold higher activity for the conjugation of genotoxic 4-hydroxycatecholestrogens at position 4, compared with the conjugation of E(2), E(1), and 2-hydroxycatecholestrogens. Its presence was further shown in the endometrium by RT-PCR and immunohistochemistry, localizing in the same cells expressing CYP1B1, involved locally in the formation of 4-hydroxycatecholestrogens. Data show that several UGT enzymes detected in the endometrium are involved in the glucuronidation of E(2) and its 2-OH, 4-OH, and 2-MeO metabolites that exert various biological effects in the tissue.

1 August 2017 in Gynecologic Oncology
Verified
Journal Article
Closed access
MPMArie Plante
MArie Plante
JSJonathan Stanleigh
Jonathan Stanleigh
MRMarie-Claude Renaud
Marie-Claude Renaud
ASAlexandra Sebastianelli
Alexandra Sebastianelli
KGKatherine Grondin
Katherine Grondin
JGJean Grégoire
Jean Grégoire